In a groundbreaking study that reshapes our understanding of immune cell metabolism, researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) have unveiled a pivotal role for mitochondrial electron flow in maintaining dendritic cells in a “ready-to-respond” state. This critical discovery links the finely tuned dynamics of cellular metabolism directly to gene regulation and the activation of T cells, offering promising new pathways to enhance vaccines and cancer immunotherapy.
Dendritic cells serve as the immune system’s sentinels, orchestrating defense mechanisms by detecting pathogens and orchestrating T cell responses to infections and tumors. Historically, the role of mitochondria during dendritic cell activation has been underestimated, seen largely as energy producers. However, this new study challenges that perception, demonstrating that the mitochondrial respiratory chain’s electron transport is essential for preserving the functional preparedness of dendritic cells, especially a specialized subset called cDC1, known for their efficacy in priming tumor-killing T cells.
Led by David Sancho at CNIC and Stefanie K. Wculek at the Institute for Research in Biomedicine (IRB Barcelona), with Ignacio Heras Murillo as first author, the research leveraged genetically engineered mouse models alongside human dendritic cells to investigate mitochondrial function. Their surprising finding was that immune readiness does not hinge primarily on ATP generation, the classic energy currency of cells, but rather on maintaining a continuous flow of electrons through the mitochondrial electron transport chain.
The team found that this electron flow preserves the cell’s internal biochemical equilibrium, including its redox state and metabolite concentrations, which play a decisive role in regulating gene expression. In collaboration with epigenetics specialists, the investigators demonstrated that disrupting this electron flow led to substantial changes in DNA methylation at critical regulatory regions—molecular switches responsible for rapid gene activation. Among the factors involved, the enzyme TET2 emerged as a key regulator; its activity could be enhanced by interventions such as vitamin C supplementation, which improved dendritic cell function in experimental settings.
Functionally, impairing mitochondrial electron flow severely hampered dendritic cell performance: these cells exhibited reduced activation markers, impaired migration to lymph nodes, and a diminished capacity to stimulate T cells efficiently. This cascade of dysfunction translated into weakened anti-tumor immune responses, highlighting the profound impact of mitochondrial metabolism on immune surveillance and cancer control. These insights position mitochondrial electron flux as a metabolic checkpoint crucial for immune cell efficacy.
Moreover, the research team successfully demonstrated that restoring mitochondrial electron flow could rescue dendritic cell functionality without increasing classical energy production. By introducing an alternative enzyme known as alternative oxidase (AOX), they reinstated electron transport and recovered the cells’ capacity to activate T cells and control tumor growth in mouse models. This innovative metabolic reprogramming highlights the potential for new therapeutic strategies targeting the mitochondrial electron transport system to boost immune responses.
This study identifies a previously unrecognized “electron flow checkpoint” that governs the immunogenic responsiveness of dendritic cells. Such a finding opens exciting possibilities for enhancing dendritic cell-based therapies, particularly in oncological contexts where immune activation is compromised. By fine-tuning mitochondrial metabolism, researchers may unlock new avenues for vaccine development and immunotherapy.
The researchers emphasize that these metabolic processes transcend mere bioenergetics; they underpin the epigenetic and transcriptional landscape that equips dendritic cells to rapidly respond to danger signals. This nuanced view underscores the intricate interplay between cellular metabolism and immune regulation, shedding light on how metabolic pathways govern immune readiness at a molecular level.
This advance also expands the understanding of TET2 regulation and its role in maintaining the epigenetic state necessary for immune activation. It suggests that modulating metabolic and epigenetic circuits in dendritic cells holds substantial promise for therapeutic innovation, including in diseases marked by immune suppression or evasion, such as cancer.
Supported by extensive national and international funding, including Spanish and European scientific bodies, the study exemplifies the power of interdisciplinary collaboration spanning immunology, metabolism, and epigenetics. The findings have been detailed in Cell Metabolism, offering a comprehensive technical foundation for future research.
The groundbreaking work by CNIC and IRB Barcelona represents a major leap in immunometabolism research. By revealing the vital dependence of dendritic cell function on mitochondrial electron flow, this study heralds a paradigm shift in immunotherapy strategies and provides a new conceptual framework for understanding immune cell regulation.
This metabolic insight promises to catalyze the development of novel clinical interventions aimed at fine-tuning dendritic cell activity. Ultimately, such therapies may significantly improve outcomes in cancer treatment and vaccine efficacy, paving the way for more precise and effective immune modulation.
Subject of Research: Cells
Article Title: Mitochondrial metabolism regulates the immunogenic responsiveness of dendritic cells
News Publication Date: 15-Apr-2026
Web References: http://dx.doi.org/10.1016/j.cmet.2026.03.012
Image Credits: CNIC
Keywords: Immunometabolism, Dendritic Cells, Mitochondrial Electron Transport, T-cell Activation, Epigenetics, Cancer Immunotherapy, TET2, Metabolic Checkpoint
Tags: cDC1 role in cancer immunotherapydendritic cell metabolism and activationenhancing vaccines through mitochondrial functiongene regulation in dendritic cellsgenetically engineered mouse models in immunologyhuman dendritic cells mitochondrial studyimmune cell metabolic dynamicsmetabolic control of dendritic cellsmitochondrial electron flow in immune cellsmitochondrial influence on tumor immunitymitochondrial respiratory chain in immune responseT cell priming by mitochondria
